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Abstract: Introduction: The use of prolonged local drug delivery to the oral 
cavity offers multiple benefits, such as increasing the pharmacological action 
in the desirable local site and reducing the usual dose and the adverse effects. 
Pilocarpine is a cholinergic drug approved by the FDA for the treatment of 
glandular hypofunction; however, the extent of its adverse effects limits its 
use. Objective: The main aim of this study was to analyze the physical and 
chemical properties of films, including pH, thickness, solubility, consistency 
and the ability to release pilocarpine for a prolonged time. Additionally, the 
antimicrobial activity in two opportunistic pathogens in hyposialia (Strepto-
coccus mutans and Candida albicans) was also assessed. Methodology: Chito-
san and HPMC (Methocel K4M CR) films were prepared in 1% acetic acid 
and pilocarpine was added under magnetic stirring. PH, thickness and time 
of solubility in artificial saliva, as well as diffusion and drug release kinetics 
per cm2 (OD=420nm) were assessed by spectrophotometry. The antimicrobial 
activity was tested by disk diffusion test against St. mutans ATCC 700610 and 
C. albicans ATCC 90029 at concentrations of hyposalivation (1.44x1.2x106 
CFU and 103 CFU, respectively). Results:  All the films, except for Hydroxy-
propyl methylcellulose / Pilocarpine formulation, were found to have optimal 
physical-chemical properties for handling, maintaining drug diffusion in 76% 
per cm2 for four hours extended-release without showing antimicrobial acti-
vity at concentrations of hyposalivation. Conclusion: The films had optimum 
handling properties and a constant drug release; however, antimicrobial acti-
vity was not found. 
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INTRODUCTION.
The use of prolonged local drug delivery to the oral 
cavity offers greater advantages in comparison with the 
systemic administration. It increases pharmacological ac-
tion at the specific site, reduces the usual dose and the 
adverse effects1.
Polymeric matrices of chitosan, which is a carbohydra-
te derived from chitin obtained from the exoskeletons of 
crustaceans, are active as absorption enhancers at low and 
high molecular weights2 because of their low degree of 
deacetylation. Chitosan has haemostatic properties, ser-
ves as osteoconductive material for bone regeneration3 and 
as vehicle for extended drug release4. It also has antimi-
crobial activity against Streptococcus mutans and Candida 
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spp.5. Apart from that, it has application for parenteral, 
oral and ocular administration, tissue engineering, and 
different mucosal tissues, among others2.
Likewise, Hydroxypropyl methylcellulose (HPMC) is 
a hygroscopic cellulose ether6 used for prolonged drug 
release7. It has the capacity to form a gel layer in the 
periphery of the biofilms on aqueous liquids, constantly 
releasing the drug through pores in the matrix8.
The system of HPMC and chitosan polymeric matrices 
for controlled drug release provides the mechanical pro-
perties for the desired application6,9. Also, they have to be 
biocompatible, biodegradable, and avoid inf lammatory, 
immunological and cytotoxic response10.
Physical-chemical properties of the controlled-release 
systems containing chitosan and HPMC using films for 
transdermal and oral models, such as pH, tension-elonga-
tion, uniformity of drug diffusion and solubility11,12,13,14, 
have been studied proving beneficial for systems as a fu-
ture application15.
Currently, models containing Chitosan and HPMC16,17 
have been developed for in vivo and in vitro oral admi-
nistration for prolonged release of drugs like lidocaine1, 
ibuprofen18, fluconazole19 and metronidazole, as promising 
means of intraoral matrices20.
Pilocarpine is the first drug approved by the FDA 
(Federal Drug Administration) for treating deterioration 
of salivary glands21,22,23. However, it has many adverse 
effects such as sweating, rhinitis, nausea, increased 
urinary frequency, as well as increased gastrointestinal 
secretion of hydrochloric acid24,25, and it is contraindicated 
for many ailments26,27.
An attempted has been made to find an alternative way 
to deliver pilocarpine in xerostomia using mouthwashes of 
pilocarpine in saline solution. It gave good results with 2% 
pilocarpine. However, it was not found to be effective 90 
minutes after using the mouthwash24.
The aim of this study was to evaluate physical-chemical 
properties (pH, thickness, solubility, uniformity and drug 
time release) and antimicrobial properties of films made of 
chitosan and HPMC biopolymers with pilocarpine with 
the purpose of proposing an alternative treatment for hy-
posalivation by increasing salivary flow and inhibiting the 
growth of the two main opportunistic microorganisms. 
MATERIALS AND METHODS.
Preparation of chitosan and Hydroxypropyl methyl-
cellulose biofilms with pilocarpine. 
To carry out the experimental studies, chitosan with a 
75% degree of deacetylation, obtained from Sigma-Aldrich 
Chemical Company (St. Louis, Missouri, US.), Hydroxy-
propyl methylcellulose (Methocel K4M CR) donated by 
Colorcon from Mexico (Cuajimalpa, Edo. Of Mexico) 
and pilocarpine obtained from the GLOBAL laboratory 
(Monterrey, N. L., Mexico) were used.
There were six formulations: chitosan (1g/100ml), 
HPMC (1.5g/100ml), chitosan/HPMC (0.5gr in 
every/100ml), which were taken as a basis for the reali-
zation of the treatments and added with a weight dose of 
pilocarpine for rats (0.15gr/mL of Pilocarpine). The formu-
lations were homogenized under magnetic stirring in an 
aqueous solution of 1% acetic acid at 70ºC for one hour. 
Then, they were put into Petri dishes for drying in the 
open air for 24 hours, to later be detached (Figure 1).
Evaluation of physicochemical properties.
With the aim to know the physicochemical properties 
of the biofilm, pH (Beckman potentiometer), thickness 
(Mitutoyo Digimatic 1”) (Figure 2) and the time of so-
lubility in 24 ml of artificial saliva, which is the amount 
of saliva secreted by diabetic patients in the course of an 
hour, were evaluated.
Determining uniformity of diffusion of Pilocarpine 
in the films.
In order to determine uniformity of Pilocarpine in 
the films, 0.15gr of Pilocarpine were dissolved in 25ml 
of distilled water under magnetic stirring at 37ºC for 
an hour, absorbing with a spectrophotometer (BIORAD 
Smart Spec 3000) at different optical densities (OD) 
(200nm - 500nm) to obtain a reference value to consider 
as a control. Thus, the optical density which revealed 
higher absorbance (420nm) was taken into account.
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Once the value of control with pilocarpine was obtai-
ned, 1cm2 of the chitosan/HPMC/Pilocarpine film was 
dissolved in 25ml of distilled water at 37oC under magne-
tic stirring for one hour to later measure the absorbance 
with the purpose of obtaining the value of pilocarpine 
content in the films.
Assessment of the release time of pilocarpine
To determine the time of release of the drug of the 
chiitosan/HPMC/pilocarpine film, 1cm2 of the film was 
placed in 25ml of distilled water at 37°C under magnetic 
stirring. Besides, absorbance was measured every 15 mi-
nutes for 4 hours at an OD of 420nm, which was deter-
mined during the drug uniformity test, with the goal of 
creating release kinetics. 
Evaluation of the antimicrobial activity of the film. 
The antimicrobial effect of the films was evaluated 
against the two opportunistic pathogens causing the 
main diseases present in hyposalivation, using Strepto-
coccus mutans strains ATCC 700610 in a culture me-
dium of brain heart infusion (ICC) and Candida albicans 
ATCC 90029 in a culture medium of YPD (yeast pepto-
ne Dextrose).  The cellular concentrations of the strains, 
Streptococcus mutans (1.44x106 CFU) and Candida albi-
cans (1.2x103 CFU), were adjusted to the concentrations 
found in diabetic patients with hyposalivation, based on 
the pattern of 0.5 McFarland with the purpose of obtai-
ning the cellular patterns. The technique of disk diffu-
sion was used with 1cm2 of the films.
RESULTS.
Evaluation of the physicochemical properties.
pH:
Results showed that, given the acidification of the 
acetic acid, the films showed a variable pH around 3, 
in which chitosan increased pH, being the HPMC films 
the more acidic, which maintained a stable pH below 3 
(Table 1).
Determining thickness:
The average uniform thickness of each formulation 
varied in extent depending on the grain of the polymers 
Figure 1. Ch/HPMC/P films
Film detachment after 24 hours drying
to form pores. HPMC had a thinner thickness compared 
with the chitosan film and it was even seen at the mo-
ment of solubility, being the thinnest films the first ones 
to dissolve in artificial saliva (Table 2). 
Films Solubility:
HPMC and HPMC/Pilocarpine films dissolved in an 
average time of 33±0.1 min, and the other formulations, 
such as Ch and Ch/HPMC and the one supplemented 
with pilocarpine completely dissolved 48 hours after 
being placed in artificial saliva.
Drug diffusion per cm2:
For determining the uniformity of the Pilocarpine in 
Ch/HPMC/P films, the average absorbance of Pilocar-
pine dissolved in 25ml of saliva at an OD of 420nm was 
considered as a control. It was 0.056±0,014 A. Afterwards, 
absorbance was made to the film under the same condi-
tions, which showed 0.043±0.004 A, then, it was unifor-
mly 0.11gr (76%) per cm2 out of 0.15gr (100%).
Drug release kinetics: 
Regarding uniformity of the drug, release kinetics of 
pilocarpine showed that the percentage of absorbance at 
the time of release was 71%, 89% after 2 hours, 82% af-
ter 3 hours and 129% after 4 hours (Figure 3).
Antimicrobial evaluation of the films:
Using the diffusion technique in well with the aim to 
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Figure 2. Film thickness measurements.
Figure 3. Extended release of pilocarpine.
Table 1. PH of films.
Table 2. Film thickness (μ).
The five areas where the thickness of the biofilms 
was measured using a micrometer are shown 
(Mitutoyo Digimatic 1”).
Prolonged release kinetics of pilocarpine of 
Ch/HPMC/P films per time. 
PH of  films. Ch= Chitosan, HPMC= hydroxypropyl methylcellulose, 
P= pilocarpine.
Thickness of the film by micrometer. Ch= Chitosan, 
HPMC= hydroxypropyl methylcellulose, P= pilocarpine.
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evaluate the antimicrobial activity of the cellular patterns 
found in diabetic patients with hyposalivation, Strep-
tococcus  mutans (1.44x106 CFU) and Candida albicans 
(1.2x103 CFU), showed that none of the films presented 
effective antimicrobial activity against the two organisms 
evaluated.
DISCUSSION.
Currently, due to the increase in infectious diseases, 
there is a need to prevent and eradicate the problems 
which are very commonly found within the oral cavity 
with higher prevalence in sufferings which increase the-
se diseases, as hyposalivation, in which Candida albicans 
and Streptococcus  mutans are actively involved28.
In 2011, Souza et al.3 became interested in effectively 
finding MIC and MBC values of chitosan in gel at di-
fferent concentrations against Streptococcus mutans which 
were a p>1.25 and p<2.50, respectively. This is consistent 
with Tapia et al., who, in 20099, found MIC and MBC va-
lues of chitosan against different Candida spp., including 
Candida albicans, by broth microdilution method. They 
found that the species were inhibited at concentrations 
below 1.25mg/ml of chitosan. In comparison with our 
results, not effective antimicrobial activity of chitosan 
against strains of Streptococcus mutans and Candida albi-
cans was found using the disk diffusion technique. This 
can be attributed to the inability of chitosan to diffuse in 
agar as film, resulting in a negative antimicrobial effect. 
However, with the increased salivary production which 
this biofilm would cause by stimulating exocrine glands, 
the line of defense and the enzyme systems which this 
f luid has would increase. This would reduce the level of 
risk for opportunistic infections in hyposalivation.
In 2008, Juliano et al.29 conducted a study in which 
they tested prolonged release of chlorhexidine through 
HPMC and chitosan films and, using in vitro tests, de-
termined the uniformity of the drug in the films, which 
was found in 72% of the drug expected. Then, it was 
tested in vivo in the oral cavity of healthy patients per-
forming release kinetics of the drug using saliva samples, 
   CH HPMC CH/HPMC CH/P HPMC/P CH/HPMCP
 3.98±  2.88±   3.60± 3.95±  2.89±  3.60±
 0.04    64   0.005 0.01  0.02  0.01
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finding the highest concentration (33.18gr/mL) 120 min 
after the application, still above MIC of Candida albicans 
(7.8mg/mL) 15 min after the application. This is consis-
tent with our result in which we found a uniformity of 
76% of pilocarpine. However, the time when it shows 
the greatest concentration of pilocarpine was at 240 min 
(0.07338 A), during the realization of the in vitro release 
kinetics. This offers a constant release of the drug, which 
when placed locally in the oral cavity may persistently 
stimulate salivary f low and be an alternative treatment 
for hyposalivation, decreasing oral diseases and reducing 
the adverse effects of pilocarpine.
Nowadays, new treatment alternatives at eye level with 
nanoparticles chitosan2 have been developed. Due to 
their optimum properties of biodegradability, biocom-
patibility, non-toxicity and mucoadhesiveness, and given 
the high bacterial resistance to ophthalmological level, 
they promise an alternative delivery treatment for drugs, 
which has been compared in the treatment of glaucoma, 
so that by comparing the conditions that are found in the 
oral cavity and the best conditions encountered in this 
study through the films. It would be important to assess 
mucosa of the oral cavity for their in vivo study30.
CONCLUSION.
All the films were found to have optimal physicoche-
mical properties for handling, with an adequate diffusion 
(72%) and a constant release of the drug for 4 hours after 
their placement in an aqueous medium. However, although 
the films did not showed antimicrobial activity, when sti-
mulating salivation it would be expected the enzyme sys-
tems increase, which would help the natural inhibition of 
these microorganisms. Given the results obtained from the 
films, they can be considered an alternative choice to alle-
viate the symptoms and reduce the adverse effects of the 
usual administration of pilocarpine.
Evaluación fisico-química y antimicrobiana de 
biopelículas de quitosán e hidroxipropilmetilcelulo-
sa para liberación prolongada de pilocarpina.
Resumen: Introducción: El uso local de administra-
ción prolongada de fármacos en la cavidad oral pro-
porciona múltiples ventajas, aumentando la acción far-
macológica en el sitio local deseable, reducción de la 
dosis usual y disminución de los efectos adversos. La 
pilocarpina es una droga colinérgica aprobada por la 
FDA para el tratamiento de la hipofunción glandular, 
sin embargo la amplitud de sus efectos adversos limitan 
su uso. Objetivo: Con el objetivo de analizar las pro-
piedades físico-químicas de las biopelículas se evaluó 
el pH, grosor, solubilidad, uniformidad y la capacidad 
de liberar prolongadamente pilocarpina, así como su 
actividad antimicrobiana ante los dos microorganismos 
patógenos oportunistas en la hiposialia (Streptococcus 
mutans y Candida albicans). Metodología: Se elabo-
raron biopelículas de Quitosán e Hidroxipropilmetil-
celulosa  (Methocel K4MCR) en ácido acético al 1%, 
adicionadas con pilocarpina bajo agitación magnética, 
evaluando el pH, grosor y el tiempo de solubilidad en 
saliva artificial, así como la uniformidad de difusión 
y cinética de liberación de la droga por cm2 mediante 
espectrofotometría (OD=420nm). Mediante difusión 
en disco se evaluó la actividad antimicrobiana ante 
Streptococcus mutans ATCC 700610 y Candida albicans 
ATCC 90029 en concentraciones encontradas en hipo-
salivación (1.44 x 106 UFC y 1.2 x 103 UFC respectiva-
mente). Resultados: Todas las biopelículas, a excepción 
de la formulación Hidroxipropilmetilcelulosa e Hidro-
xipropilmetilcelulosa/Pilocarpina resultaron tener las 
propiedades físico-químicas óptimas de manipulación, 
manteniendo una uniformidad de difusión de la droga 
en 76% por cm2 con liberación prolongada por 4 horas, 
sin mostrar actividad antimicrobiana en concentracio-
nes de hiposalivación. Conclusión: Las películas obtu-
vieron las propiedades óptimas de manipulación, y una 
constante liberación del fármaco, sin embargo, ninguna 
formulación presentó actividad antimicrobiana
Palabras clave:  Biopelículas, Pilocarpina, Hiposali-
vación, Quitosán
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